Health Sciences Acquisitions 2 Statistics Share Statistics Health Sciences Acquisitions 2 has n/a
shares outstanding. The number of shares has increased by -45.17%
in one year.
Shares Outstanding n/a Shares Change (YoY) -45.17% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 5.12M Failed to Deliver (FTD) Shares 49 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 256.92K, so 0% of the outstanding
shares have been sold short.
Short Interest 256.92K Short % of Shares Out n/a Short % of Float 4.06% Short Ratio (days to cover) 2.02
Valuation Ratios The PE ratio is -8031.07 and the forward
PE ratio is null.
Health Sciences Acquisitions 2's PEG ratio is
0.
PE Ratio -8031.07 Forward PE n/a PS Ratio 185780.16 Forward PS n/a PB Ratio 14870.08 P/FCF Ratio -9638.49 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Health Sciences Acquisitions 2.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.27,
with a Debt / Equity ratio of 0.07.
Current Ratio 4.27 Quick Ratio 4.26 Debt / Equity 0.07 Debt / EBITDA -0.03 Debt / FCF -0.04 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0.03 Inventory Turnover 1.18
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Health Sciences Acquisitions 2's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 10.07 200-Day Moving Average 9.96 Relative Strength Index (RSI) 96.86 Average Volume (20 Days) 71,375
Income Statement In the last 12 months, Health Sciences Acquisitions 2 had revenue of 2.64M
and earned -61.02M
in profits. Earnings per share was -1.66.
Revenue 2.64M Gross Profit 2.43M Operating Income -64.3M Net Income -61.02M EBITDA -64.3M EBIT n/a Earnings Per Share (EPS) -1.66
Full Income Statement Balance Sheet The company has 22.26M in cash and 2.24M in
debt, giving a net cash position of 20.02M.
Cash & Cash Equivalents 22.26M Total Debt 2.24M Net Cash 20.02M Retained Earnings -309.88M Total Assets 42.83M Working Capital 18.82M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -50.56M
and capital expenditures -289K, giving a free cash flow of -50.85M.
Operating Cash Flow -50.56M Capital Expenditures -289K Free Cash Flow -50.85M FCF Per Share 0
Full Cash Flow Statement Margins Gross margin is 92.27%, with operating and profit margins of -2437.49% and -2313.27%.
Gross Margin 92.27% Operating Margin -2437.49% Pretax Margin -2313.27% Profit Margin -2313.27% EBITDA Margin -2437.49% EBIT Margin -2437.49% FCF Margin -1927.48%
